| Bioactivity | Norswertianin, a xanthone compound, serves as a powerful anti-glioma compound. Norswertianin induces GBM cells differentiation through oxidative stress and Akt/mTOR dependent autophagy[1]. |
| Invitro | Norswertianin (12.5-50 µM; 48 hours) stimulats expression of GFAP and β-tubulin in U251 cells[1].Norswertianin (40 µM; 48 hours) causes the appearance of elongated processes in U251 cells, associated with G2/M cell cycle arrest[1].Norswertianin (40 µM; 48 hours) exhibits an increase in intracellular acidification and LC3 conversion[1]. |
| Name | Norswertianin |
| CAS | 22172-15-2 |
| Formula | C13H8O6 |
| Molar Mass | 260.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Norswertianin
CAS: 22172-15-2 F: C13H8O6 W: 260.20
Norswertianin, a xanthone compound, serves as a powerful anti-glioma compound. Norswertianin induces GBM cells different
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.